CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Aether Therapeutics Inc. v. RedHill Biopharma Inc.

1:21-cv-00248

Overview

Case Number 1:21-cv-00248
Filing Date 2021-02-22
Status Terminated
Termination Date 2023-04-06
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:1 Patent Infringement
Jury Demand Plaintiff

Parties

Defendant

RedHill Biopharma Inc. Operating Company

Represented By

8 Attorneys Listed

Wyley S. Proctor

Email: wproctor@mccarter.com

Kasey E. Koballa

Email: kkoballa@kilpatricktownsend.com

Michael E. Furrow

Email: mfurrow@kilpatricktownsend.com

Gabrielle Markeson

Email: amarkeson@kilpatricktownsend.com

Courtney S. Dabbiere

Email: cdabbiere@kilpatricktownsend.com

April Abele Isaacson

Email: aisaacson@kilpatricktownsend.com

Alexandra M. Joyce

McCarter & English, LLP

Tel: +1 (302) 984-6392
Fax: +1 (302) 450-4235

Renaissance Centre, 405 N. King Street, 8th Floor

Daniel M. Silver

McCarter & English, LLP

Tel: +1 (302) 984-6300
Fax: +1 (302) 691-1260

Renaissance Centre, 405 N. King Street, 8th Floor

Plaintiff

Aether Therapeutics Inc. Operating Company

Represented By

8 Attorneys Listed

Paul S. Danner

Email: pdanner@goldbergsegalla.com

Emma L. Freedenberg

Email: efreedenberg@goldbergsegalla.com

Cedric C. Y. Tan

Email: ctan@goldbergsegalla.com

Michael J. Barresi

Email: mbarresi@goldbergsegalla.com

Lynn Lehnert

Email: llehnert@goldbergsegalla.com

Kenneth A. Matuszewski

Email: kmatuszewski@goldbergsegalla.com

Richard Charles Weinblatt

Stamoulis & Weinblatt LLC

Tel: +1 (302) 999-1540

Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor

Stamatios Stamoulis

Stamoulis & Weinblatt LLC

Tel: +1 (302) 999-1540

Stamoulis & Weinblatt LLC, 800 N. West Street, Third Floor

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 1 proceeding
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (1 found):
U.S. Courts: 1
U.S. District Court 2020-03-18
1:20-cv-00381

Aether Therapeutics Inc. v. AstraZeneca AB

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

4 Patents

There are 4 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6713488
Neutral antagonists and use thereof in treating drug abuse
Filed: 2002-06-14
Issued: 2004-03-30
Expired (Term Ended)
Expires: 2022-06-14
US8748448
Combination analgesic employing opioid agonist and neutral antagonist
Filed: 2012-11-28
Issued: 2014-06-10
Active (6.0 yrs remaining)
Expires: 2032-11-28
US8883817
Combination analgesic employing opioid and neutral antagonist
Filed: 2008-10-17
Issued: 2014-11-11
Active (4.5 yrs remaining) +943d PTA
Expires: 2031-05-18
US9061024
Combination analgesic employing opioid agonist and neutral antagonist
Filed: 2014-05-15
Issued: 2015-06-23
Active (7.5 yrs remaining)
Expires: 2034-05-15

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

71

Dispositive

10

Granted

5

Denied

0

Pending / Review

50

Motions by Category

Claim Construction / Markman Filing 33 Procedural / Extension Motion 26 Motion for Summary Judgment (Rule 56) 8 Motion for Summary Judgment (Invalidity) 2 Motion to Stay 2

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Pending / Under Review
ANSWERING BRIEF in Opposition re 189 MOTION for Summary Judgment filed by Aether Therapeutics Inc..Reply Brief due date per Local Rules is 3/1/2023. (Attachment...
Entry #202 • 2023-02-22 Document →
Motion for Summary Judgment (Rule 56) Granted
SO ORDERED re (232 in 1:20-cv-00381-MN, 187 in 1:21-cv-00248-MN) MOTION for Leave to File a Declaration of David W.C. MacMillan, Ph.D. - IT IS HEREBY ORDERED th...
Entry #β€” • 2023-02-10
Motion for Summary Judgment (Rule 56) Pending / Under Review
STATEMENT // Defendants' Concise Statement of Material Facts as to Which There is No Genuine Issue In Support of Their Motion for Summary Judgment by RedHill Bi...
Entry #188 • 2023-02-08 Document →
Motion for Summary Judgment (Rule 56) Pending
MOTION for Summary Judgment - filed by RedHill Biopharma Inc.. (Attachments: # 1 Text of Proposed Order)(Joyce, Alexandra) (Entered: 02/08/2023)
Entry #189 • 2023-02-08 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
MOTION for Summary Judgment - filed by RedHill Biopharma Inc.. (Attachments: # 1 Text of Proposed Order)(Joyce, Alexandra) (Entered: 02/08/2023)
Entry #189 • 2023-02-08 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
OPENING BRIEF in Support re 189 MOTION for Summary Judgment filed by RedHill Biopharma Inc..Answering Brief/Response due date per Local Rules is 2/22/2023. (Att...
Entry #190 • 2023-02-08 Document →

Docket Entries

(347 total)
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against RedHill Biopharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3537308.) - filed by Aether Therapeutics Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Civil Cover Sheet)(myr) (Entered: 02/23/2021)

Entry #1 • 2021-02-22
1
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against RedHill Biopharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3537308.) - filed by Aether Therapeutics Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Civil Cover Sheet)(myr) (Entered: 02/23/2021)

Entry #1 • 2021-02-22
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against RedHill Biopharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3537308.) - filed by Aether Therapeutics Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Civil Cover Sheet)(myr) (Entered: 02/23/2021)

Entry #1 • 2021-02-22
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against RedHill Biopharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3537308.) - filed by Aether Therapeutics Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Civil Cover Sheet)(myr) (Entered: 02/23/2021)

Entry #1 • 2021-02-22
2
Pleading / Complaint

COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against RedHill Biopharma Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3537308.) - filed by Aether Therapeutics Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Civil Cover Sheet)(myr) (Entered: 02/23/2021)

Entry #1 • 2021-02-22
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc